Cutler Group LP Oramed Pharmaceuticals Inc. Transaction History

Cutler Group LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	BUY	$4.6 - $9.91 $5,579 - $12,020	1,213 Added 242.6%	1,713 $11,000
Q2 2022 Aug 04, 2022	SELL	$3.72 - $9.0 $744 - $1,800	-200 Reduced 28.57%	500 $2,000
Q1 2022 Apr 14, 2022	BUY	$8.19 - $13.89 $5,733 - $9,723	700 New	700 $6,000

7.4M

2.1K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $90.9M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.